{"id":64341,"date":"2025-05-06T19:36:25","date_gmt":"2025-05-06T19:36:25","guid":{"rendered":"https:\/?p=64341"},"modified":"2025-05-07T02:20:30","modified_gmt":"2025-05-07T02:20:30","slug":"analyst-ratings-coverage-update-may-6th-2025","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/","title":{"rendered":"Analyst Ratings Coverage Update: May 6th 2025"},"content":{"rendered":"

Analyst Ratings<\/a><\/h2>\n

The overall analyst sentiment from today’s analyst coverage updates is “Neutral” to “Slightly Bearish”, with pockets of optimism in select company names.<\/p>\n

Here are the latest analyst updates:<\/strong><\/p>\n

AECOM (ACM)<\/strong> had its target price raised by Robert W. Baird from $108.00 to $118.00 while maintaining an Outperform<\/em> rating.<\/p>\n

Affirm Holdings (AFRM)<\/strong> had its target price lowered by Morgan Stanley from $65.00 to $60.00 while maintaining an Equal Weight<\/em> rating.<\/p>\n

Aflac (AFL)<\/strong> had its target price raised by Wells Fargo & Company from $102.00 to $103.00 while maintaining an Equal Weight<\/em> rating.<\/p>\n

Air Canada (AC:CA)<\/a><\/strong> had its target price lowered by Raymond James from $28.00 to $24.00 while maintaining a Market Perform<\/em> rating.<\/p>\n

Albemarle (ALB)<\/strong> had its target price lowered by Bank of America from $68.00 to $58.00, maintaining an Underweight<\/em> rating.<\/p>\n

Albemarle (ALB)<\/strong> also had its target price lowered by Citigroup from $80.00 to $60.00 while maintaining a Neutral<\/em> rating.<\/p>\n

Allison Transmission (ALSN)<\/strong> had its target price raised by Morgan Stanley from $94.00 to $100.00 while maintaining an Equal Weight<\/em> rating.<\/p>\n

Allstate (ALL)<\/strong> had its target price lowered by Wells Fargo & Company from $200.00 to $197.00 while maintaining an Equal Weight<\/em> rating.<\/p>\n

Allstate (ALL)<\/strong> also had its target price raised by Jefferies Financial Group from $225.00 to $235.00 while maintaining an Overweight<\/em> rating.<\/p>\n

Alphabet Inc. (GOOGL)<\/strong> had its rating reiterated by JMP Securities as Market Perform<\/em>.<\/p>\n

AMC Networks (AMCX)<\/strong> had its target price lowered by JPMorgan Chase & Co. from $8.00 to $6.00 while maintaining an Underweight<\/em> rating.<\/p>\n

Ameren (AEE)<\/strong> had its target price raised by Barclays from $101.00 to $104.00 while maintaining an Equal Weight<\/em> rating.\\<\/p>\n

Ameresco (AMRC)<\/strong> had its target price raised by Craig Hallum from $27.00 to $29.00 while maintaining a Buy<\/em> rating.<\/p>\n

Ameresco (AMRC)<\/strong> also had its target price set by Evercore ISI at $21.00 while maintaining an Overweight<\/em> rating.<\/p>\n

American Eagle Outfitters (AEO)<\/strong> had its target price lowered by Morgan Stanley from $12.00 to $11.00 while maintaining an Equal Weight<\/em> rating.<\/p>\n

American International Group (AIG)<\/strong> had its target price raised by Morgan Stanley from $80.00 to $81.00 while maintaining an Equal Weight<\/em> rating.<\/p>\n

AnaptysBio (ANAB)<\/strong> had its target price raised by Guggenheim from $52.00 to $54.00 while maintaining a Buy<\/em> rating.<\/p>\n

Andersons (ANDE)<\/strong> had its rating initiated by BMO Capital Markets with a Market Perform<\/em> rating and a price target of $45.00.<\/p>\n

Angel Oak Mortgage REIT (AOMR)<\/strong> had its rating reiterated by Jones Trading as Buy<\/em> with a price target of $10.50.<\/p>\n

AptarGroup (ATR)<\/strong> had its rating reiterated by Wells Fargo & Co. as Overweight<\/em> with a price target raised from $162.00 to $170.00.<\/p>\n

Ares Capital (ARCC)<\/strong> had its target price lowered by Royal Bank of Canada from $24.00 to $23.00 while maintaining an Outperform<\/em> rating.<\/p>\n

Ares Management (ARES)<\/strong> had its target price raised by Barclays from $142.00 to $182.00 while maintaining an Overweight<\/em> rating.<\/p>\n

Ares Management (ARES)<\/strong> also had its target price raised by Wells Fargo & Co. from $156.00 to $182.00 while maintaining an Overweight<\/em> rating.<\/p>\n

Artisan Partners Asset Management (APAM)<\/strong> had its target price raised by Royal Bank of Canada from $43.00 to $44.00 while maintaining an Outperform<\/em> rating.<\/p>\n

Artivion (AORT)<\/strong> had its rating reiterated by Needham & Company LLC as Buy<\/em> with a price target of $32.00.<\/p>\n

Artivion (AORT)<\/strong> also had its rating reiterated by JMP Securities as Market Outperform<\/em> with a price target of $33.00.<\/p>\n

Ashland (ASH)<\/strong> had its target price lowered by JPMorgan Chase & Co. from $71.00 to $67.00 while maintaining an Overweight<\/em> rating.<\/p>\n

AXIS Capital (AXS)<\/strong> had its target price raised by Wells Fargo & Co. from $100.00 to $104.00 while maintaining an Equal Weight<\/em> rating.<\/p>\n

Axsome Therapeutics (AXSM)<\/strong> had its rating reiterated by Wells Fargo & Co. as Overweight<\/em> with a price target raised from $160.00 to $165.00.<\/p>\n

Axsome Therapeutics (AXSM)<\/strong>: Robert W. Baird raised the target price to $162.00 from $160.00, maintaining an “Outperform” rating.<\/p>\n

Bank First (BFC)<\/strong>: Hovde Group upgraded the rating to “Outperform” from “Market Perform,” setting a target price of $130.00.<\/p>\n

Barrett Business Services (BBSI)<\/strong>: Barrington Research reiterated the “Outperform” rating, keeping the target price at $45.00.<\/p>\n

Bath & Body Works (BBWI)<\/strong>: Morgan Stanley lowered the target price to $43.00 from $49.00, maintaining an “Overweight” rating.<\/p>\n

Bausch + Lomb (BLCO)<\/strong>: Morgan Stanley reduced the target price to $12.00 from $18.00, keeping the “Equal Weight” rating.<\/p>\n

Baytex Energy Corp. (BTE:CA)<\/strong>: Raymond James, TD Securities, and National Bank all lowered their target prices to $3.50, $4.50, and $5.00, respectively, while maintaining their ratings of “Market Perform,” “Buy,” and “Outperform.”<\/p>\n

Becton, Dickinson and Company (BDX)<\/strong>: Morgan Stanley lowered the target price to $196.00 from $280.00, maintaining the “Overweight” rating.<\/p>\n

BioCryst Pharmaceuticals (BCRX)<\/strong>: JPMorgan Chase & Co. and Needham & Company raised the target price to $13.00 from $10.00 and to $17.00 from $15.00, respectively, maintaining an “Overweight” and “Buy” rating.<\/p>\n

Biomea Fusion (BMEA)<\/strong>: D. Boral Capital and HC Wainwright reiterated the “Buy” rating, with the target price unchanged at $16.00 and $18.00, respectively.<\/p>\n

BioNTech (BNTX)<\/strong>: Morgan Stanley lowered the target price to $132.00 from $140.00, maintaining the “Overweight” rating. Citigroup reiterated the “Buy” rating, lowering the target price to $140.00 from $145.00.<\/p>\n

Bright Horizons Family Solutions (BFAM)<\/strong>: Morgan Stanley raised the target price to $106.00 from $100.00, maintaining the “Underweight” rating.<\/p>\n

Broadridge Financial Solutions (BR)<\/strong>: Needham & Company initiated a “Buy” rating with a target price of $300.00.<\/p>\n

Builders Capital Mortgage Corp (BCF:CA)<\/strong>: Fundamental Research initiated a “Buy” rating with a target price of $9.92.<\/p>\n

Burlington Stores (BURL)<\/strong>: Morgan Stanley lowered the target price to $269.00 from $297.00, maintaining the “Overweight” rating.<\/p>\n

Cable One (CABO)<\/strong>: JPMorgan Chase & Co. lowered the target price to $222.00 from $325.00, maintaining the “Neutral” rating.<\/p>\n

Cactus (WHD)<\/strong>: JPMorgan Chase & Co. lowered the target price to $52.00 from $54.00, maintaining the “Neutral” rating.<\/p>\n

Canaan (CAN)<\/strong>: Benchmark initiated a “Buy” rating with a target price of $3.00.<\/p>\n

Canadian National Railway (CNI)<\/strong>: Susquehanna upgraded the rating to “Positive” from “Neutral,” setting a target price of $120.00.<\/p>\n

Castle Biosciences (CSTL)<\/strong>: Canaccord Genuity Group lowered the target price to $37.00 from $42.00, maintaining the “Buy” rating.<\/p>\n

Cedar Fair (FUN)<\/strong>: Morgan Stanley lowered the target price to $47.00 from $58.00, maintaining the “Overweight” rating.<\/p>\n

Celldex Therapeutics (CLDX)<\/strong>: HC Wainwright reiterated the “Buy” rating, with the target price unchanged at $80.00.<\/p>\n

Certara (CERT)<\/strong>: JMP Securities reiterated the “Market Perform” rating, with no target price change.<\/p>\n

Chevron (CVX)<\/strong>: DZ Bank downgraded the rating to “Sell” from “Buy,” setting a target price of $130.00.<\/p>\n

Church & Dwight (CHD)<\/strong>: TD Cowen downgraded the rating to “Hold” from “Buy,” setting a target price of $100.00.<\/p>\n

Clorox (CLX)<\/strong>: Wells Fargo & Company, JPMorgan Chase & Co., and Morgan Stanley lowered the target prices to $142.00, $144.00, and $150.00, respectively, maintaining the “Equal Weight,” “Neutral,” and “Equal Weight” ratings.<\/p>\n

Coinbase Global (COIN)<\/strong>: Monness Crespi & Hardt downgraded the rating to “Neutral” from “Buy,” with no target price change.<\/p>\n

Comcast (CMCSA)<\/strong>: Argus downgraded the rating to “Hold” from “Buy,” with no target price change.<\/p>\n

Conagra Brands (CAG)<\/strong>: JPMorgan Chase & Co. lowered the target price to $25.00 from $26.00, maintaining the “Neutral” rating.<\/p>\n

Controladora Vuela Compa\u00f1\u00eda de Aviaci\u00f3n (VLRS)<\/strong>: JPMorgan Chase & Co. lowered the target price to $7.00 from $13.00, maintaining the “Overweight” rating.<\/p>\n

Corcept Therapeutics (CORT)<\/strong>: HC Wainwright lowered the target price to $145.00 from $150.00, maintaining the “Buy” rating.<\/p>\n

Corebridge Financial (CRBG)<\/strong>: Barclays raised the target price to $38.00 from $36.00, maintaining the “Overweight” rating.<\/p>\n

CorMedix (CRMD)<\/strong>: D. Boral Capital reiterated the “Buy” rating, with no target price change.<\/p>\n

Coterra Energy (CTRA)<\/strong>: Barclays lowered the target price to $35.00 from $37.00, maintaining the “Overweight” rating.<\/p>\n

CT REIT (CRT.UN:CA)<\/strong>: Scotiabank raised the target price to $16.50 from $16.00, maintaining the “Outperform” rating.<\/p>\n

Cummins (CMI)<\/strong>: JPMorgan Chase & Co. raised the target price to $320.00 from $308.00, maintaining the “Neutral” rating. Morgan Stanley raised the target price to $350.00 from $340.00, maintaining the “Overweight” rating.<\/p>\n

CVS Health (CVS)<\/strong>: Wells Fargo & Company reiterated the “Overweight” rating, raising the target price to $84.00 from $76.00.<\/p>\n

Denny’s (DENN)<\/strong>: Oppenheimer lowered the target price to $6.00 from $7.00, maintaining the “Outperform” rating.<\/p>\n

Diamondback Energy (FANG)<\/strong>: Evercore ISI initiated an “Outperform” rating with a target price of $165.00.<\/p>\n

FrontView REIT, Inc. (FVR)<\/strong>: Bank of America downgraded the stock from Buy to Neutral with a price target of $15.00.<\/p>\n

Fulgent Genetics (FLGT)<\/strong>: Piper Sandler reiterated a Neutral rating on the stock.<\/p>\n

GAP (GAP)<\/strong>: Morgan Stanley lowered the target price from $30.00 to $27.00, maintaining an Overweight rating.<\/p>\n

GE HealthCare Technologies (GEHC)<\/strong>: Morgan Stanley lowered the target price from $86.00 to $78.00, maintaining an Equal Weight rating.<\/p>\n

Genius Sports (GENI)<\/strong>: Needham & Company LLC reiterated a Buy rating with a price target of $13.00.<\/p>\n

Glaukos Co. (GKOS)<\/strong>: Morgan Stanley lowered the target price from $110.00 to $72.00, maintaining an Underweight rating.<\/p>\n

Globe Life Inc. (GL)<\/strong>: Wells Fargo & Company lowered the target price from $140.00 to $139.00, maintaining an Overweight rating.<\/p>\n

GoDaddy (GDDY)<\/strong>: JPMorgan Chase & Co. raised the target price from $231.00 to $240.00, maintaining an Overweight rating.<\/p>\n

Gray Television, Inc. (GTN)<\/strong>: Benchmark lowered the target price from $8.00 to $7.00, maintaining a Buy rating.<\/p>\n

Green Impact Partners Inc. (GIP:CA)<\/strong>: Canaccord Genuity downgraded the stock from Speculative Buy to Hold, lowering the price target from $6.00 to $3.00.<\/p>\n

Guardant Health, Inc. (GH)<\/strong>: Piper Sandler reiterated an Overweight rating with no target price provided.<\/p>\n

Haleon plc (HLN)<\/strong>: Barclays reiterated an Overweight rating with no target price provided.<\/p>\n

Harmony Biosciences Holdings, Inc. (HRMY)<\/strong>: Needham & Company LLC reiterated a Buy rating with a price target of $49.00.<\/p>\n

HBT Financial, Inc. (HBT)<\/strong>: Hovde Group upgraded the stock from Market Perform to Outperform with a price target of $28.00.<\/p>\n

Henry Schein, Inc. (HSIC)<\/strong>: Wells Fargo & Company lowered the target price from $80.00 to $75.00, maintaining an Equal Weight rating.<\/p>\n

Hims & Hers Health, Inc. (HIMS)<\/strong>: Citigroup reiterated a Sell rating with a price target raised from $25.00 to $30.00.<\/p>\n

Hydro One Ltd. (H:CA)<\/strong>: Desjardins Securities initiated a Buy rating with a price target of $58.00.<\/p>\n

Ichor Holdings, Ltd. (ICHR)<\/strong>: TD Cowen lowered the target price from $38.00 to $28.00, maintaining a Buy rating.<\/p>\n

Immuneering Co. (IMRX)<\/strong>: Chardan Capital reiterated a Buy rating with a price target of $13.00.<\/p>\n

Imperial Oil Ltd. (IMO:CA)<\/strong>: Desjardins Securities raised the target price from $85.00 to $89.00, maintaining a Hold rating.<\/p>\n

Inspire Medical Systems, Inc. (INSP)<\/strong>: Wells Fargo & Company lowered the target price from $195.00 to $174.00, maintaining an Equal Weight rating.<\/p>\n

Integra LifeSciences Holdings Co. (IART)<\/strong>: JPMorgan Chase & Co. lowered the target price from $24.00 to $12.00, maintaining an Underweight rating.<\/p>\n

Invitation Homes Inc. (INVH)<\/strong>: Oppenheimer raised the target price from $39.00 to $41.00, maintaining an Outperform rating.<\/p>\n

James River Group Holdings, Ltd. (JRVR)<\/strong>: JMP Securities reiterated a Market Outperform rating with a price target of $8.00.<\/p>\n

Janus Henderson Group plc (JHG)<\/strong>: Morgan Stanley raised the target price from $32.00 to $33.00, maintaining an Equal Weight rating.<\/p>\n

Kinder Morgan, Inc. (KMI)<\/strong>: JPMorgan Chase & Co. raised the target price from $29.00 to $30.00, maintaining a Neutral rating.<\/p>\n

Laboratory Co. of America Holdings (LH)<\/strong>: Piper Sandler reiterated a Neutral rating with no target price provided.<\/p>\n

Lakeland Financial (LKFN)<\/strong>: Hovde Group upgraded the stock from Market Perform to Outperform with a price target of $72.00.<\/p>\n

Lattice Semiconductor Co. (LSCC)<\/strong>: Several analysts raised target prices, with TD Cowen increasing it from $50.00 to $58.00, Benchmark maintaining a $60.00 target, and Needham & Company LLC reiterating a Buy rating with a price target of $70.00.<\/p>\n

Leonardo DRS (DRS)<\/strong>: Morgan Stanley raised the target price from $34.00 to $44.00, maintaining an Equal Weight rating.<\/p>\n

Liberty Global Ltd. (LBTYA)<\/strong>: Barclays maintained an Equal Weight rating with a target price lowered from $12.00 to $11.00.<\/p>\n

Lincoln Electric Holdings, Inc. (LECO)<\/strong>: Morgan Stanley raised the target price from $179.00 to $180.00, maintaining an Underweight rating.<\/p>\n

Lineage, Inc. (LINE)<\/strong>: Bank of America downgraded the stock from Buy to Neutral, raising the price target from $43.00 to $49.00.<\/p>\n

Logitech International S.A. (LOGI)<\/strong>: Loop Capital lowered the target price from $97.00 to $78.00, maintaining a Hold rating.<\/p>\n

Lowe’s Companies, Inc. (LOW)<\/strong>: JPMorgan Chase & Co. lowered the target price from $300.00 to $263.00, maintaining an Overweight rating.<\/p>\n

Macy’s, Inc. (M)<\/strong>: Morgan Stanley lowered the target price from $14.00 to $12.00, maintaining an Equal Weight rating.<\/p>\n

Madison Square Garden Sports Corp. (MSGS)<\/strong>: Guggenheim reiterated a Buy rating with a price target of $314.00.<\/p>\n

MARA Holdings, Inc. (MARA)<\/strong>: Compass Point downgraded the stock from Neutral to Sell with a price target lowered from $25.00 to $9.50.<\/p>\n

Martin Marietta Materials, Inc. (MLM)<\/strong>: Morgan Stanley raised the target price from $561.00 to $576.00, maintaining an Overweight rating.<\/p>\n

Matson, Inc. (MATX)<\/strong>: Jefferies Financial Group reiterated a Buy rating with a price target of $125.00, while Stephens lowered the target price from $175.00 to $150.00, maintaining an Overweight rating.<\/p>\n

Mattel, Inc. (MAT)<\/strong>: Morgan Stanley raised the target price from $16.00 to $17.00, maintaining an Equal Weight rating.<\/p>\n

McDonald’s Co. (MCD)<\/strong>: Northcoast Research downgraded the stock from Buy to Neutral, with no price target provided.<\/p>\n

Mercer International Inc. (MERC)<\/strong>: CIBC World Markets lowered the target price to $6.00, maintaining a Neutral rating.<\/p>\n

MetLife, Inc. (MET)<\/strong>: Wells Fargo & Company raised the target price from $91.00 to $94.00, maintaining an Overweight rating.<\/p>\n

Mohawk Industries, Inc. (MHK)<\/strong>: JPMorgan Chase & Co. lowered the target price from $156.00 to $139.00, maintaining an Overweight rating.<\/p>\n

monday.com Ltd. (MNDY)<\/strong>: JPMorgan Chase & Co. lowered the target price from $400.00 to $350.00, maintaining an Overweight rating.<\/p>\n

Napco Security Technologies, Inc. (NSSC)<\/strong>: Needham & Company LLC lowered the target price from $37.00 to $32.00, maintaining a Buy rating.<\/p>\n

National Grid plc (NGG)<\/strong>: Citigroup reiterated a Buy rating with no target price provided.<\/p>\n

Navitas Semiconductor Co. (NVTS)<\/strong>: Needham & Company LLC lowered the target price from $4.00 to $3.00, maintaining a Buy rating.<\/p>\n

Neurocrine Biosciences, Inc. (NBIX)<\/strong>: Multiple analysts raised target prices, including UBS Group raising it from $137.00 to $152.00, while Guggenheim raised it from $155.00 to $165.00, maintaining Buy ratings.<\/p>\n

Nexstar Media Group, Inc. (NXST)<\/strong> had its price target lowered by Benchmark, maintaining a Buy rating with a new target of $215.00, down from $225.00.<\/p>\n

NIKE, Inc. (NKE)<\/strong> saw its price target lowered by Telsey Advisory Group, keeping a Market Perform rating with a new target of $70.00, down from $80.00.<\/p>\n

Norwegian Cruise Line Holdings Ltd. (NCLH)<\/strong> had its price target lowered by Morgan Stanley, maintaining an Equal Weight rating with a new target of $20.00, down from $21.00.<\/p>\n

Ocular Therapeutix, Inc. (OCUL)<\/strong> saw its price target lowered by Needham & Company LLC, maintaining a Buy rating with a new target of $14.00, down from $15.00.<\/p>\n

Olin Co. (OLN)<\/strong> had its price target raised by Wells Fargo & Company, maintaining an Equal Weight rating with a new target of $22.00, up from $19.00.<\/p>\n

Olin Co. (OLN)<\/strong> had its price target lowered by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $20.00, down from $28.00.<\/p>\n

Olympic Steel (ZEUS)<\/strong> had its price target lowered by KeyCorp, maintaining an Overweight rating with a new target of $41.00, down from $43.00.<\/p>\n

Onsemi (ON)<\/strong> had its price target raised by TD Cowen, maintaining a Buy rating with a new target of $44.00, up from $38.00.<\/p>\n

Onsemi (ON)<\/strong> had its price target reiterated by Rosenblatt Securities, maintaining a Neutral rating with no change to the target of $42.00.<\/p>\n

Onsemi (ON)<\/strong> had its price target lowered by Robert W. Baird, maintaining a Neutral rating with a new target of $34.00, down from $42.00.<\/p>\n

Onsemi (ON)<\/strong> had its price target lowered by Needham & Company LLC, maintaining a Buy rating with a new target of $50.00, down from $57.00.<\/p>\n

Onsemi (ON)<\/strong> had its price target lowered by Wells Fargo & Company, maintaining an Overweight rating with a new target of $45.00, down from $60.00.<\/p>\n

Onsemi (ON)<\/strong> had its price target lowered by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $48.00, down from $60.00.<\/p>\n

Onsemi (ON<\/strong>) had its price target lowered by Benchmark, maintaining a Buy rating with a new target of $50.00, down from $60.00.<\/p>\n

Orbia Advance Co., S.A.B. de C.V. (MXCHY)<\/strong> had its rating reiterated by Barclays with an Overweight rating and no change to the target.<\/p>\n

Palantir Technologies Inc. (PLTR)<\/strong> had its price target raised by Mizuho, maintaining an Underperform rating with a new target of $94.00, up from $80.00.<\/p>\n

Palantir Technologies Inc. (PLTR)<\/strong> had its price target raised by Morgan Stanley, maintaining an Equal Weight rating with a new target of $98.00, up from $90.00.<\/p>\n

Palantir Technologies Inc. (PLTR)<\/strong> had its price target raised by Cantor Fitzgerald, maintaining a Neutral rating with a new target of $110.00, up from $98.00.<\/p>\n

Palantir Technologies Inc. (PLTR)<\/strong> had its price target raised by UBS Group, maintaining a Neutral rating with a new target of $110.00, up from $105.00.<\/p>\n

Palantir Technologies Inc. (PLTR)<\/strong> had its rating reiterated by Deutsche Bank AG, maintaining a Sell rating.<\/p>\n

Palantir Technologies Inc. (PLTR)<\/strong> had its price target set by Wedbush, maintaining an Outperform rating with a target of $140.00.<\/p>\n

Parkland Corp. (PKI:CA)<\/strong> had its price target raised by National Bank, with a new target of $42.00, up from $41.00.<\/p>\n

Parkland Corp. (PKI:CA)<\/strong> had its price target lowered by TD Securities, changing from a Buy rating to a Sell rating with a new target of $44.00, down from $50.00.<\/p>\n

Parkland Corp. (PKI:CA)<\/strong> had its price target lowered by Scotiabank, maintaining an Outperform rating with a new target of $44.00, down from $52.00.<\/p>\n

Paymentus Holdings, Inc. (PAY)<\/strong> had its price target raised by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $35.00, up from $29.00.<\/p>\n

Paymentus Holdings, Inc. (PAY<\/strong>) had its price target raised by Robert W. Baird, maintaining an Outperform rating with a new target of $36.00, up from $30.00.<\/p>\n

Pinterest, Inc. (PINS)<\/strong> had its price target lowered by Benchmark, maintaining a Buy rating with a new target of $45.00, down from $55.00.<\/p>\n

PRA Group, Inc. (PRAA)<\/strong> had its price target lowered by JMP Securities, maintaining a Market Outperform rating with a new target of $23.00, down from $30.00.<\/p>\n

Premium Brands Holdings Corp. (PBH:CA)<\/strong> had its price target lowered by RBC Capital, maintaining a Sector Perform rating with a new target of $97.00, down from $98.00.<\/p>\n

Principal Financial Group (PFG) h<\/strong>ad its price target raised by Morgan Stanley, maintaining an Underweight rating with a new target of $67.00, up from $65.00.<\/p>\n

Prudential Financial, Inc. (PRU<\/strong>) had its price target raised by Wells Fargo & Company, maintaining an Equal Weight rating with a new target of $113.00, up from $108.00.<\/p>\n

Quanta Services, Inc. (PWR<\/strong>) had its price target set by Piper Sandler, maintaining an Overweight rating with a target of $360.00.<\/p>\n

Quest Diagnostics (DGX<\/strong>) had its price target raised by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $190.00, up from $180.00.<\/p>\n

ServiceNow, Inc. (NOW)<\/strong> had its price target reiterated by Oppenheimer, maintaining an Outperform rating with a new target of $1,100.00, up from $970.00.<\/p>\n

ServiceNow, Inc. (NOW)<\/strong> had its price target reiterated by Needham & Company LLC, maintaining a Buy rating with a target of $1,050.00.<\/p>\n

ServiceNow, Inc. (NOW)<\/strong> had its price target reiterated by JMP Securities, maintaining a Market Outperform rating with a target of $1,300.00.<\/p>\n

Shopify Inc. (SHOP:CA)<\/strong> had its price target lowered by ATB Capital, maintaining a Sector Perform rating with a new target of $120.00, down from $170.00.<\/p>\n

Shopify Inc. (SHOP)<\/strong> had its price target set by BMO Capital Markets, maintaining an Outperform rating with a target of $120.00 USD.<\/p>\n

Tenaris (TS)<\/strong> had its price target set by Barclays, maintaining an Overweight rating with a new target of $48.00, down from $50.00.<\/p>\n

The Gap, Inc. (GAP)<\/strong> had its price target lowered by Morgan Stanley, maintaining an Overweight rating with a new target of $27.00, down from $30.00.<\/p>\n

The Home Depot, Inc. (HD)<\/strong> had its price target lowered by JPMorgan Chase & Co., maintaining an Overweight rating with a new target of $410.00, down from $470.00.<\/p>\n

The Marcus Co. (MCS)<\/strong> had its rating reiterated by Barrington Research, maintaining an Outperform rating with a target of $25.00.<\/p>\n

TransAlta Corp. (TA:CA) had its price target lowered by Desjardins Securities, maintaining a Hold rating with a new target of $14.00, down from $16.00.<\/p>\n

TVA Group Inc (TVA.B:CA)<\/strong> had its rating downgraded by National Bank from Sector Perform to Underperform with a new target of $0.25, down from $1.00.<\/p>\n

Twist Bioscience (TWST)<\/strong> had its price target lowered by JPMorgan Chase & Co., maintaining an Underweight rating with a new target of $33.00, down from $40.00.<\/p>\n

Twist Bioscience (TWST)<\/strong> had its rating reiterated by Guggenheim, maintaining a Buy rating with no change to the target of $50.00.<\/p>\n

Twist Bioscience (TWST)<\/strong> had its price target lowered by Robert W. Baird, maintaining an Outperform rating with a new target of $44.00, down from $54.00.<\/p>\n

Tyson Foods (TSN)<\/strong> had its price target lowered by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $61.00, down from $63.00.<\/p>\n

Tyson Foods (TSN)<\/strong> had its price target lowered by Stephens, maintaining an Equal Weight rating with a new target of $61.00, down from $63.00.<\/p>\n

United Parks & Resorts Inc. (PRKS)<\/strong> had its price target lowered by Morgan Stanley, maintaining an Equal Weight rating with a new target of $50.00, down from $56.00.<\/p>\n

Upwork (UPWK)<\/strong> had its price target reiterated by Needham & Company LLC, maintaining a Buy rating with no change to the target of $19.00.<\/p>\n

Upwork (UPWK)<\/strong> had its price target lowered by Citigroup, maintaining a Neutral rating with a new target of $18.00, down from $19.00.<\/p>\n

Urban Outfitters (URBN)<\/strong> had its price target lowered by Morgan Stanley, maintaining an Overweight rating with a new target of $62.00, down from $63.00.<\/p>\n

Veralto (VLTO)<\/strong> had its rating initiated by Northcoast Research, maintaining a Buy rating with a target of $110.00.<\/p>\n

Vertex Pharmaceuticals (VRTX)<\/strong> had its price target raised by Morgan Stanley, maintaining an Equal Weight rating with a new target of $464.00, up from $462.00.<\/p>\n

Vertex Pharmaceuticals (VRTX)<\/strong> had its price target raised by JPMorgan Chase & Co., maintaining an Overweight rating with a new target of $515.00, up from $512.00.<\/p>\n

Vertex Pharmaceuticals (VRTX)<\/strong> had its rating reiterated by Cantor Fitzgerald, maintaining an Overweight rating with a target of $535.00.<\/p>\n

Vertex Pharmaceuticals (VRTX)<\/strong> had its rating reiterated by Leerink Partners, upgrading its rating from Market Perform to Outperform with a new target of $503.00.<\/p>\n

Vertex Pharmaceuticals (VRTX)<\/a><\/strong> had its rating reiterated by Needham & Company LLC, maintaining a Hold rating with no change to the target.<\/p>\n

Vimeo (VMEO)<\/strong> had its price target set by Piper Sandler, maintaining an Overweight rating with a target of $8.00.<\/p>\n

Wajax Corp (WJX:CA)<\/strong> had its price target raised by BMO Capital Markets, with a new target of $22.00, up from $20.00.<\/p>\n

Waldencast (WALD)<\/strong> had its rating reiterated by Telsey Advisory Group, maintaining an Outperform rating with a target of $5.00.<\/p>\n

Walmart (WMT)<\/strong> had its rating reiterated by Royal Bank of Canada, maintaining an Outperform rating with no change to the target of $102.00.<\/p>\n

Wendy’s (WEN)<\/strong> had its price target lowered by BMO Capital Markets, maintaining a Market Perform rating with a new target of $15.00, down from $17.00.<\/p>\n

Westlake (WLK)<\/strong> had its price target lowered by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $82.00, down from $110.00.<\/p>\n

Westlake (WLK)<\/strong> had its price target lowered by Wells Fargo & Company, maintaining an Overweight rating with a new target of $95.00, down from $110.00.<\/p>\n

Westlake (WLK)<\/strong> had its price target lowered by BMO Capital Markets, maintaining a Market Perform rating with a new target of $103.00, down from $125.00.<\/p>\n

Westrock Coffee (WEST)<\/strong> had its rating reiterated by Telsey Advisory Group, maintaining an Outperform rating with a target of $9.00.<\/p>\n

Westshore Terminals Investment Corp.<\/strong> (WTE:CA) had its price target lowered by RBC Capital, maintaining a Sector Perform rating with a new target of $23.00, down from $25.00.<\/p>\n

Wolverine World Wide (WWW)<\/strong> had its price target raised by Robert W. Baird, maintaining an Outperform rating with a new target of $20.00, up from $15.00.<\/p>\n

Workday (WDAY)<\/strong> had its rating initiated by Westpark Capital with a Buy rating and a target of $315.00.<\/p>\n

Wyndham Hotels & Resorts (WH)<\/strong> had its price target lowered by Robert W. Baird, maintaining an Outperform rating with a new target of $99.00, down from $107.00.<\/p>\n

Yorkton Equity Group Inc (YEG:CA)<\/strong> had its rating initiated by Fundamental Research, maintaining a Buy rating with a target of $0.34.<\/p>\n

Zimmer Biomet (ZBH<\/strong>) had its price target lowered by Wells Fargo & Company, maintaining an Equal Weight rating with a new target of $98.00, down from $113.00.<\/p>\n

Zimmer Biomet (ZBH)<\/strong> had its price target lowered by JPMorgan Chase & Co., maintaining an Overweight rating with a new target of $105.00, down from $128.00.<\/p>\n

Zimmer Biomet (ZBH)<\/strong> had its price target lowered by Robert W. Baird, maintaining an Outperform rating with a new target of $115.00, down from $130.00.<\/p>\n

Zimmer Biomet (ZBH)<\/strong> had its price target updated by Stifel Nicolaus, maintaining a target of $115.00.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings The overall analyst sentiment from today’s analyst coverage updates is “Neutral” to “Slightly Bearish”, with pockets of optimism in select company names. Here…<\/p>\n","protected":false},"author":3,"featured_media":61306,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64341","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"\nAnalyst Ratings Coverage Update: May 6th 2025 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analyst Ratings Coverage Update: May 6th 2025\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings The overall analyst sentiment from today’s analyst coverage updates is “Neutral” to “Slightly Bearish”, with pockets of optimism in select company names. Here...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-06T19:36:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-07T02:20:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2025\/02\/image-50.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"18 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Analyst Ratings Coverage Update: May 6th 2025\",\"datePublished\":\"2025-05-06T19:36:25+00:00\",\"dateModified\":\"2025-05-07T02:20:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/\"},\"wordCount\":3854,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/\",\"name\":\"Analyst Ratings Coverage Update: May 6th 2025 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2025-05-06T19:36:25+00:00\",\"dateModified\":\"2025-05-07T02:20:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analyst Ratings Coverage Update: May 6th 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Analyst Ratings Coverage Update: May 6th 2025 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/","og_locale":"en_US","og_type":"article","og_title":"Analyst Ratings Coverage Update: May 6th 2025","og_description":"Analyst Ratings The overall analyst sentiment from today’s analyst coverage updates is “Neutral” to “Slightly Bearish”, with pockets of optimism in select company names. Here...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2025-05-06T19:36:25+00:00","article_modified_time":"2025-05-07T02:20:30+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2025\/02\/image-50.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"18 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Analyst Ratings Coverage Update: May 6th 2025","datePublished":"2025-05-06T19:36:25+00:00","dateModified":"2025-05-07T02:20:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/"},"wordCount":3854,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/","name":"Analyst Ratings Coverage Update: May 6th 2025 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2025-05-06T19:36:25+00:00","dateModified":"2025-05-07T02:20:30+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-coverage-update-may-6th-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Analyst Ratings Coverage Update: May 6th 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/64341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=64341"}],"version-history":[{"count":21,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/64341\/revisions"}],"predecessor-version":[{"id":64380,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/64341\/revisions\/64380"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/61306"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=64341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=64341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=64341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}